Skip to main content

4.6M Filipinos to benefit from new anti-anginal drug





About 4.6 million Filipinos suffering from chronic stable angina are expected to benefit from a new drug that was introduced at the Philippine Heart Association Annual Convention at the EDSA Shangri-La Manila on Thursday, May 28, 2015.

The Menarini Group, a leading Italian pharmaceutical company known worldwide for its innovative products, recently signed an exclusive long-term agreement with Gilead Sciences, Inc. to launch a new anti-anginal agent, in 140 countries, including the Philippines.

A. Menarini Philippines, Inc. said the novel drug is designed to help millions of Filipinos with stable angina pectoris whose symptoms have not been controlled by first-line and second-line therapy agents like beta blockers and/or calcium antagonists.

The World Health Organization1 has stated that cardiovascular diseases (CVDs) remain the No. 1 cause of death worldwide. In 2008 alone, about 17.3 million died from CVDs, representing 30% of global deaths.

WHO added that over 80% of CVD deaths take place in low- and middle-income countries, and occurs in both men and women. To make matters worse, the New England Journal of Medicine2 added that at 12 months of follow-up, 59% of patients on medical therapy still had uncontrolled angina.

In the Philippines, CVD is a leading cause of mortality and 90% of the population has one or more of the six prevalent risk factors of the disease. These are smoking, physical inactivity, hypertension, hypercholesterolemia, overweight, and obesity.

“We are delighted and honored to further strengthen our long-term partnership with Gilead to help address the needs of angina patients in these new territories, in particular the Asia Pacific region,” said Alberto Giovanni Aleotti, vice president of the Menarini Group.

Menarini is an international pharmaceutical company with over 16,000 employees worldwide in more than 100 countries in Europe, Asia, Latin America, Africa, and the Middle East, and has a 2012 turnover of over €3 billion. It ranks 17th in Europe and 34th in the world, according to the IMS World Review 2012.

The Group has 14 manufacturing sites located in Italy and abroad where over 545 million packages yearly are produced and distributed throughout the five continents, ensuring the health of patients all over the world. For more information, visit http://www.menarini.com/

References:
1.      Global status report on non-communicable diseases 2010. Geneva, World Health   Organization, 2011
2.       N Engl J Med 2007; 356:1503-1516 April 12, 2007

Press Release
 
Labels:

Comments

Post a Comment

Popular posts from this blog

Transforming Lives: The Impact of SM Group's KSK Program on Filipino Farmers

  Farming futures Jayson and Juanito proudly showcase a selection of produce at the SM City Clark’s Weekend Market. While modern agricultural techniques boost yields for some, there remains a number of Filipino farmers who struggle to keep pace. These experienced hands find themselves falling behind in a market demanding higher production, clinging to familiar yet often inefficient methods passed down through generations. One farmer from Pampanga, Jayson Garcia, sought to disrupt this prevailing narrative in his family. He knew that he had to chart a new course forward for his farm and innovate to remain competitive within the rapidly evolving landscape of modern agriculture. “Noon, mahirap ang magtanim,” he recalled their life before joining SM Foundation’s Kabalikat sa Kabuhayan. “Para bang tsambahan, basta pag itinanim mo ‘yan, hintayin mo na lang mamunga. Mas mahirap pa lalo kapag nagkaroon ng kalamidad,” he added.  SM Foundation’s training program focused on high-value cr...
Post a Comment
Read more

Bioessence 30 Years of Beauty and Wellness: Caring Beyond Beauty

  Caring Beyond Beauty Bioessence PH, one of the country's premier beauty brands, celebrated its 30th anniversary last night with an elegant Pearl Anniversary event.   Held on September 26 at The Blue Leaf Cosmopolitan, the night gathered nearly a thousand guests, including VIPs, loyal clients, media, influencers, and special performers, to enjoy an evening dedicated to beauty and wellness.   " We will continue to CARE for you Beyond BEAUTY...I love you and God bless you all! " - Dra. Emma Beleno, founder Bioessence Themed around #CaringBeyondBeauty, the event focused on Bioessence's innovative approaches to care that extend far beyond their products and services. The atmosphere was filled with energy, as attendees experienced a fresh take on beauty and wellness, along with a variety of activities designed to showcase the brand’s vision for the future. New Ambassadress Unveiled  One of the most exciting moments of the evening was the reveal of Bioessenc...
Post a Comment
Read more

Venue Infrastructure Challenges Concert Experience in the Philippines

Countries with better, bigger, and more competitive concert venues have reaped economic benefits, especially with the massive and significant influence of popular international acts like pop superstar Taylor Swift’s Eras Tour and Coldplay’s World Tour in consumer behavior and spending.  Driving tens of thousands of ‘Swifties’ and concert enthusiasts, the success of these concerts was an economic stimulus for countries worldwide, including Southeast Asian countries such as Singapore and Japan.  Filipino fans alike had to spend big and travel miles to watch the exclusive performance of superstar Swift in Singapore’s National Stadium while others went to Japan’s Tokyo Dome and Sydney’s Accor Stadium in Australia. The massive concert gigs boosted the respective country’s economies, benefitting entertainment, hospitality, retail, and transport industries significantly. While Singapore’s strategy for a Southeast Asia exclusive Swift performance piqued interest and likewise piqued it...
Post a Comment
Read more